Differential changes in potency of platelet-aggregation inhibitors after preincubation in platelet-rich plasma.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010949:Plasma; D010973:Platelet Adhesiveness / Q000187:drug effects*; D013552:Swine; D013997:Time Factors; D014268:Trifluoperazine / Q000494:pharmacology
D000639:Amitriptyline; D014268:Trifluoperazine; D002110:Caffeine; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D004155:Diphenhydramine; D010208:Papaverine; D007099:Imipramine; D002746:Chlorpromazine